<DOC>
	<DOCNO>NCT01405482</DOCNO>
	<brief_summary>Botulinum toxin type A injected anterior middle scalene muscle reduce irritation neurovascular structure interscalene triangle subject TOS . This lead reduction pain paresthesia , improvement function compare injection placebo .</brief_summary>
	<brief_title>Botulinum Toxin Injections Thoracic Outlet Syndrome</brief_title>
	<detailed_description>To assess effect Botulinum Toxin Type A ( BTX-A ) injection scalene muscle pain , paresthesias function subject TOS . Hypothesis : BTX-A injected anterior middle scalene muscle reduce irritation neurovascular structure interscalene triangle subject TOS . This lead reduction pain paresthesia , improvement function compare injection placebo . Study design : Double-blind , randomize , placebo-controlled parallel group effectiveness trial evaluate change pain , paresthesias function , six week four month follow injection . Study population : Sixty subject least eighteen year age clinical diagnosis TOS least three month duration le one year , refer practice management TOS . Intervention : Each subject receive injection EMG guidance anterior middle scalene muscle either 100 unit BTX-A ( experimental group ) , normal saline ( control group ) . Outcome measure : The primary outcome measure pain measure ten point Numeric Rating Scale two point reduction consider significant . Secondary outcome paresthesias measure Numeric Rating Scale , function measure Disabilities arm , shoulder hand ( DASH ) questionnaire .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Thoracic Outlet Syndrome</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Age least 19 year Medically stable Able give inform consent Meets criteria clinical diagnosis TOS Symptoms TOS present least three month less two year Have EMG study CT MRI scan cervical spine Prior treatment BTXA Allergy BTXA History botulinum toxicity Prior scalenectomy Surgery TOS plan within four month Use blood thinner , i.e. , warfarin ; unfractionated low molecular weight heparin History Myasthenia Gravis , EatonLambert Syndrome ShyDrager Syndrome Unable complete followup assessment 6 week 4 month Any abnormality EMG , CT MRI study suggest alternate diagnosis Pregnancy plan pregnancy within six month</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Botulinum Toxin Type A</keyword>
	<keyword>Thoracic Outlet Syndrome</keyword>
</DOC>